Article
Epigenome scans and cancer genome sequencing converge on <i>WNK2</i> , a kinase-independent suppressor of cell growth
19 Jun 2007
Abstract excerpt
Human cancer genome and epigenome projects aim to identify new cancer genes and targets for therapy that have been overlooked by conventional approaches. Here we integrated large-scale genomics and epigenomics of 31 human infiltrative gliomas and identified low-frequency deletion and highly recurrent epigenetic silencing of WNK2, encoding a putative serine/threonine kinase. Prior cancer genome sequencing projects...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
